Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidija Covic

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research|February 21, 2013
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancerRajani Kaimal, Raid Aljumaily, Sarah L Tressel, et al.
EMBO Molecular Medicine|May 19, 2011
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsisSarah L Tressel, Nicole C Kaneider, Shogo Kasuda, et al.
Thrombosis Research|March 10, 2019
Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrelCarey Kimmelstiel, Ryan Stevenson, Nga Nguyen, et al.
Blood|December 22, 2011
Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemiaKatie O'Callaghan, Lydia Lee, Nga Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2021
Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery DiseaseElizabeth K Fletcher, Yanling Wang, Laura K Flynn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2018
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisRajashree Rana, Tianfang Huang, Georgios Koukos, et al.
The American Journal of Pathology|June 28, 2011
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancerJaroslaw Cisowski, Katie O'Callaghan, Athan Kuliopulos, et al.
Annals of the New York Academy of Sciences|May 28, 2011
G protein-coupled receptor modulation with pepducins: moving closer to the clinicPatricia Dimond, Kenneth Carlson, Michel Bouvier, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research|February 21, 2013
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancerRajani Kaimal, Raid Aljumaily, Sarah L Tressel, et al.
EMBO Molecular Medicine|May 19, 2011
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsisSarah L Tressel, Nicole C Kaneider, Shogo Kasuda, et al.
Thrombosis Research|March 10, 2019
Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrelCarey Kimmelstiel, Ryan Stevenson, Nga Nguyen, et al.
Blood|December 22, 2011
Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemiaKatie O'Callaghan, Lydia Lee, Nga Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2021
Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery DiseaseElizabeth K Fletcher, Yanling Wang, Laura K Flynn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2018
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisRajashree Rana, Tianfang Huang, Georgios Koukos, et al.
The American Journal of Pathology|June 28, 2011
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancerJaroslaw Cisowski, Katie O'Callaghan, Athan Kuliopulos, et al.
Annals of the New York Academy of Sciences|May 28, 2011
G protein-coupled receptor modulation with pepducins: moving closer to the clinicPatricia Dimond, Kenneth Carlson, Michel Bouvier, et al.
Pageof 6